Chemoproteomics-Enabled Covalent Ligand Screening Reveals a Thioredoxin-Caspase 3 Interaction Disruptor That Impairs Breast Cancer Pathogenicity

Document Details

Document Type
Pub Defense Publication
Publication Date
Sep 13, 2017
Source ID
10.1021/acschembio.7b00711

Entities

People

  • Daniel Nomura
  • James A. Olzmann
  • Kimberly E. Anderson
  • Milton To

Organizations

  • American Cancer Society
  • Congressionally Directed Medical Research Programs
  • National Cancer Institute
  • National Institute of General Medical Sciences
  • Novartis